Study Summary
This trial is testing a new drug, FS120, to see if it is safe and effective in treating people with advanced cancer.
- Advanced Cancer
- Metastatic Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: 15 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
FS120 Q4W
1 of 2
FS120
1 of 2
Experimental Treatment
277 Total Participants · 2 Treatment Groups
Primary Treatment: FS120 · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the maximum number of individuals permitted to join this clinical trial?
"Absolutely, the published information on clinicaltrials.gov attests to this trial's ongoing recruitment process which commenced in November 2020 and was last updated in August of 2022. There is need for 277 volunteers across three locations." - Anonymous Online Contributor
Are there currently any vacancies for participants of this clinical trial?
"Indeed, the information posted on clinicaltrials.gov confirms that this study is still open for recruitment. It was initially listed on November 18th 2020 and most recently updated in August 8th 2022. The researchers are aiming to acquire 277 patients from 3 different sites." - Anonymous Online Contributor
Has the FS120 medication been given clearance by the FDA?
"FS120 is currently being assessed in a Phase 1 trial, thus the safety rating for this medication was registered as a score of 1 due to scant evidence indicating its efficacy and security." - Anonymous Online Contributor